Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
Clinical trial NCT00485576 · COMPLETED
Trial details
- NCT number
- NCT00485576
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-09-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.